CytomX Therapeutics
CTMX
CTMX
120 hedge funds and large institutions have $614M invested in CytomX Therapeutics in 2025 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 103 → 120 (+17)
1.68% more ownership
Funds ownership: 83.33% → 85.01% (+1.7%)
Holders
120
Holding in Top 10
1
Calls
$6.14M
Puts
$360K
Top Buyers
| 1 | +$35.3M | |
| 2 | +$20.2M | |
| 3 | +$17.1M | |
| 4 |
EP
Eversept Partners
New York
|
+$9.52M |
| 5 |
Financial Engines Advisors
Santa Clara,
California
|
+$9.3M |
Top Sellers
| 1 | -$35.3M | |
| 2 | -$18.8M | |
| 3 | -$11M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.49M |
| 5 |
Renaissance Technologies
New York
|
-$8.12M |
